Cargando…

Desensitization using IVIG alone for living-donor kidney transplant: impact on donor-specific antibodies

INTRODUCTION: Sensitization to human leukocyte antigen is a barrier to. Few data have been published on desensitization using polyvalent human intravenous immunoglobulin (IVIG) alone. METHODS: We retrospectively reviewed the of 45 patients with a positive complement-dependent cytotoxicity crossmatch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ulisses, Luiz Roberto de Sousa, Paixão, Jenaine Oliveira, Agena, Fabiana, de Souza, Patrícia Soares, Paula, Flávio J, Bezerra, Gislene, Rodrigues, Hélcio, Panajotopolous, Nicolas, David-Neto, Elias, de Castro, Maria Cristina Ribeiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Nefrologia 2022
Materias:	Original Articles \|
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838666/ https://www.ncbi.nlm.nih.gov/pubmed/35438714 http://dx.doi.org/10.1590/2175-8239-JBN-2021-0200

Ejemplares similares

The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study
por: David-Neto, Elias, et al.
Publicado: (2012)

Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption
por: Kälble, Florian, et al.
Publicado: (2021)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products
por: Romero, Carolina, et al.
Publicado: (2021)

The Kinetics of Anti-HLA Antibodies in the First Year after Kidney Transplantation: In Whom and When Should They Be Monitored?
por: de Castro, Maria Cristina Ribeiro, et al.
Publicado: (2018)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products—an update
por: Romero, Carolina, et al.
Publicado: (2022)

Donor-derived TB after kidney transplantation: a case report
por: Ulisses, Luiz Roberto de Sousa, et al.
Publicado: (2021)

Early and Sustained Reduction in Donor-Specific Antibodies in Desensitized Living Donor Kidney Transplant Recipients: A 3-Year Prospective Study
por: Shaffer, David, et al.
Publicado: (2016)

Comparative analysis of kidney transplant costs related to recovery of renal function after the procedure
por: Quinino, Raquel Martins e, et al.
Publicado: (2021)

Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation
por: Jeong, Jong Cheol, et al.
Publicado: (2016)

Living Donor Liver Transplantation in Patients with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies Using Preoperative Desensitization Therapy According to Intensity of Donor-Specific Antibodies: A Single-Center Study
por: Ogawa, Kohei, et al.
Publicado: (2023)

Predictive Potential of Flow Cytometry Crossmatching in Deceased Donor Kidney Transplant Recipients Subjected to Peritransplant Desensitization
por: Osickova, Klara, et al.
Publicado: (2021)

IVIG plus Glucocorticoids versus IVIG Alone in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review and Meta-Analysis
por: Rauniyar, Robin, et al.
Publicado: (2022)

Successful Liver Transplantation Case Report from a Deceased Donor with Sickle Cell Anemia
por: Nacif, Lucas Souto, et al.
Publicado: (2018)

Tools to implement and improve blood donor hemovigilance in Brazil
por: de Almeida Neto, Cesar
Publicado: (2014)

Comparative study of thermally activated delayed fluorescent properties of donor–acceptor and donor–acceptor–donor architectures based on phenoxazine and dibenzo[a,j]phenazine
por: Izumi, Saika, et al.
Publicado: (2022)

Comparison of high-dose IVIG and rituximab versus rituximab as a preemptive therapy for de novo donor-specific antibodies in kidney transplant patients
por: Kim, Hyung Woo, et al.
Publicado: (2023)

Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
por: Akamatsu, Nobuhisa, et al.
Publicado: (2021)

Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients
por: Fernández Rivera, Constantino, et al.
Publicado: (2022)

A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy
por: Guo, Zhiliang, et al.
Publicado: (2023)

Retention of blood donors: strategies to fulfill the requirements of blood centers
por: de Almeida Neto, Cesar
Publicado: (2011)

Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics
por: DeBiasi, Roberta L.
Publicado: (2021)

Successful A2 to B Deceased Donor Kidney Transplant after Desensitization for High-Strength Non-HLA Antibody Made Possible by Utilizing a Hepatitis C Positive Donor
por: Karpel, H. Charli, et al.
Publicado: (2020)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
por: Ibrahim, Uroosa, et al.
Publicado: (2023)

Treatment of scleromyxedema with IVIg
por: Moser, David W, et al.
Publicado: (2012)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
por: Wang, Zhouping, et al.
Publicado: (2020)

Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
por: De Groot, Anne S., et al.
Publicado: (2013)

Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease
por: Zhang, Hao, et al.
Publicado: (2022)

Life events and donor lapse among blood donors in Denmark
por: Piersma, Tjeerd W., et al.
Publicado: (2019)

Profile of effective donors from organ and tissue procurement services
por: Rodrigues, Simey de Lima Lopes, et al.
Publicado: (2014)

Immunoadsorption-Based HLA Desensitization in Patients Awaiting Deceased Donor Kidney Transplantation: An Interventional, Non-Randomised, Single Cohort Study
por: Bureau, Côme, et al.
Publicado: (2023)

A Comparative Study of IVIG versus IVIG with IV Methylprednisolone in Guillain–Barre Syndrome
por: Bhattiprolu, Rahi Kiran, et al.
Publicado: (2020)

Successful Live Kidney Transplantation After Chikungunya Disease in the Donor
por: Moura-Neto, José Andrade, et al.
Publicado: (2017)

Seroprevalence of HTLV-1/2 among blood donors in the state of Maranhão, Brazil
por: de Castro Viana, Graça Maria, et al.
Publicado: (2014)

Acceptance of Donor Eggs, Donor Sperms, or Donor Embryos in Indian Infertile Couples
por: Banerjee, Kaberi, et al.
Publicado: (2018)

Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022)

Associations of health status with subsequent blood donor behavior—An alternative perspective on the Healthy Donor Effect from Donor InSight
por: van den Hurk, Katja, et al.
Publicado: (2017)

Strategies for hemodynamic maintenance of potential brain-dead donor: integrative review
por: da Fonseca, Beatriz Sousa, et al.
Publicado: (2021)

Chagasic infection among blood donors in Brazil: an integrative review
por: Cardoso, Darwin Renne Florencio, et al.
Publicado: (2018)

A Technique for the Reconstruction of the Limbs of Osteomuscular Tissue Donors
por: Vialle, Luiz Roberto Gomes, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k91o7cjouk9g9gmfg6p7f1e4qn